Literature DB >> 31351055

Evolving Trends in Machine Liver Perfusion: Comments on Clinical End Points and Selection Criteria.

Zoltan Czigany1, Frank Tacke2, Georg Lurje1.   

Abstract

Mesh：

Year:  2019        PMID： 31351055     DOI： 10.1053/j.gastro.2019.02.051

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

1.  Evaluation of the ex vivo liver viability using a nuclear magnetic resonance relaxation time-based assay in a porcine machine perfusion model.

Authors:  Qing OuYang; Guohai Liang; Xiaoyu Tan; Xiran He; Lin Zhang; Weijian Kuang; Jianxiong Chen; Shaoping Wang; Mingju Liang; Feng Huo
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 2.  Hemorheological and Microcirculatory Factors in Liver Ischemia-Reperfusion Injury-An Update on Pathophysiology, Molecular Mechanisms and Protective Strategies.

Authors:  Norbert Nemeth; Katalin Peto; Zsuzsanna Magyar; Zoltan Klarik; Gabor Varga; Mihai Oltean; Anna Mantas; Zoltan Czigany; Rene H Tolba
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

3.  The Benefits of Fibrinolysis Combined with Venous Systemic Oxygen Persufflation (VSOP) in a Rat Model of Donation after Circulatory Death and Orthotopic Liver Transplantation.

Authors:  Nadja Kröger; Zoltan Czigany; Jipin Jiang; Mamdouh Afify; Pascal Paschenda; Kazuyuki Nagai; Shintaro Yagi; René H Tolba
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 5.923

4.  New Frontiers in Organ Preservation and Hepatoprotection.

Authors:  Zoltan Czigany; René Hany Tolba
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

5.  Adenosine A2a Receptor Stimulation Attenuates Ischemia-Reperfusion Injury and Improves Survival in A Porcine Model of DCD Liver Transplantation.

Authors:  Zoltan Czigany; Eve Christiana Craigie; Georg Lurje; Shaowei Song; Kei Yonezawa; Yuzo Yamamoto; Thomas Minor; René Hany Tolba
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.